A scalable and reliable manufacturing process for Nikkomycin Z HCl on a 170 g scale has been developed and optimized. The process is characterized by a 2.3 g/L fermentation yield, 79% purification yield, and >98% relative purity of the final product. This method is suitable for further scale up and cGMP production. The Streptomyces tendae ΔNikQ strain developed during the course of this study is superior to any previously reported strain in terms of higher yield and purity of Nikkomycin Z.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579645 | PMC |
| http://dx.doi.org/10.1021/op3003294 | DOI Listing |
Publication Analysis
Top Keywords
manufacturing process
8
practical scalable
4
scalable manufacturing
4
process anti-fungal
4
anti-fungal agent
4
agent nikkomycin
4
nikkomycin scalable
4
scalable reliable
4
reliable manufacturing
4
process nikkomycin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!